Image
DEEP DIVE ANALYSIS • NSE: NEWGEN • FY26 RESULTS Newgen Software Technologies Ltd: From ₹1,336 TO ₹493 — Valuation Reset or the Next Enterprise AI Compounder?  What the Q4 FY26 Numbers Actually Reveal Beneath the Midcap IT Bloodbath By SUMAN MUKHOPADHYAY | SumanSpeaks Independent Research • June 02, 2026 Newgen Software Technologies Ltd (Rs. 493)   was last trading at a pproximately ₹493 — down nearly 63% from its 52-week high near ₹1,336. In most cases, such a collapse signals severe business deterioration. But Newgen’s FY26 financials tell a far more complicated story. The company remains debt-light, highly profitable, cash-generative, and structurally positioned in one of the most important enterprise themes globally: AI-enabled workflow orchestration. Yet the stock has suffered one of the sharpest valuation compressions in the Indian en...
Now a Bombay-based weekly recommends Jupiter Bio Science Ltd for more than 100% appreciation. Cheers!!
Now a Bombay based weekly has recommended Jupiter Bio Science Ltd. The news goes like this: "The share price of Jupiter Bioscience has corrected to attractive levels. Long-term investors can buy for 100% appreciation in 12-15 months". The scrip has already corrected to some ABSURD LEVELS and should move-up in the days to come. 
Jupiter Bio Science Ltd is doing absolutely well and there is no problem in the company according to my close sources. As per www. bseindia.com, the H1FY11 EPS is Rs.8.2. If this be the case then P/E comes to around 6.32. So if the industry P/E is 26.36, then a modest P/E of 15 can take the stock to more than Rs.120. 
But I have to ask the sources, why the company is going for such equity dilutions!! SEBI should look into the matter of Preferential Issue with close eyes....!! It is a classical case of Alok Industries Ltd of 2005-07.
However, the scrip fell probably more due to operator action than due to fundamentals. 

Comments

Popular posts from this blog